- Home
- LENZ vs EU Comparison
LENZ vs EU Comparison
Compare LENZ & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- EU
- Stock Information
- Founded
- LENZ 2019
- EU 2009
- Country
- LENZ United States
- EU United States
- Employees
- LENZ N/A
- EU N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- EU Other Metals and Minerals
- Sector
- LENZ Health Care
- EU Basic Materials
- Exchange
- LENZ Nasdaq
- EU Nasdaq
- Market Cap
- LENZ 886.2M
- EU 724.1M
- IPO Year
- LENZ 2021
- EU N/A
- Fundamental
- Price
- LENZ $34.32
- EU $3.94
- Analyst Decision
- LENZ Strong Buy
- EU Strong Buy
- Analyst Count
- LENZ 6
- EU 2
- Target Price
- LENZ $35.40
- EU $6.50
- AVG Volume (30 Days)
- LENZ 157.8K
- EU 1.1M
- Earning Date
- LENZ 11-06-2024
- EU 11-14-2024
- Dividend Yield
- LENZ N/A
- EU N/A
- EPS Growth
- LENZ N/A
- EU N/A
- EPS
- LENZ N/A
- EU N/A
- Revenue
- LENZ N/A
- EU $44,972,063.00
- Revenue This Year
- LENZ N/A
- EU N/A
- Revenue Next Year
- LENZ N/A
- EU $109.91
- P/E Ratio
- LENZ N/A
- EU N/A
- Revenue Growth
- LENZ N/A
- EU N/A
- 52 Week Low
- LENZ $2.12
- EU $3.02
- 52 Week High
- LENZ $38.93
- EU $5.05
- Technical
- Relative Strength Index (RSI)
- LENZ 62.24
- EU 53.99
- Support Level
- LENZ $31.59
- EU $3.47
- Resistance Level
- LENZ $35.40
- EU $4.00
- Average True Range (ATR)
- LENZ 2.74
- EU 0.25
- MACD
- LENZ -0.08
- EU 0.03
- Stochastic Oscillator
- LENZ 60.16
- EU 79.03
About LENZ LENZ Therapeutics Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's material properties and projects are the Rosita Project located in Texas, the Alta Mesa Uranium project in Texas, the Crownpoint and Hosta Butte Uranium Project located in New Mexico, the Dewey Burdock Project located in South Dakota, and the Gas Hills Project located in Wyoming.